Prospective replication study implicates the catechol-O-methyltransferase Val158Met polymorphism as a biomarker for the response to morphine in patients with cancer.
暂无分享,去创建一个
K. Nishio | H. Matsuoka | K. Sakai | A. Koyama | K. Nakagawa | J. Tsurutani | Y. Fujita | Chihiro Makimura | Ryo Sakamoto